Alterations in the biochemical makeup of bulk plasma IgG, or Fc glycosylation, can predict COVID-19 disease severity and vaccine antibody response, according to a recent study by researchers at RUSH University and Northwestern. ...
Feb 10, 2023
0
103
The genetic code of the new coronavirus has been found: it is closely related to the SARS virus from 2003. Professor of Molecular Virology, Eric Snijder, has been researching coronaviruses for years. We asked him a few questions ...
Feb 20, 2020
0
14
Researchers at CSIRO, Australia's national science agency, have found that SARS-CoV-2, the virus responsible for COVID-19, can survive for up to 28 days on common surfaces including banknotes, glass—such as that found on ...
Oct 11, 2020
0
14
It has become abundantly clear that coronavirus disease 19 (COVID-19), despite being transmitted by breathing in the SARS-CoV-2 virus, can have harmful effects far beyond the lungs. Now, researchers from Japan have identified ...
Jun 27, 2022
0
87
When SARS-CoV-2, the virus that causes COVID-19, infects a human cell, it quickly begins to replicate by seizing the cell's existing metabolic machinery. The infected cells churn out thousands of viral genomes and proteins ...
Mar 15, 2021
0
325
Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines. Of particular interest are neutralizing antibodies, which can block ...
Dec 16, 2020
0
134
On a Friday afternoon this past December, more than 130 scientists gathered on a Zoom meeting to talk about Omicron, the latest SARS-CoV-2 variant of concern, which has ripped across the globe with ferocious infectivity.
Feb 4, 2022
1
25
Many questions about how exposure to SARS-CoV-2 by infection or immunization might result in long-term protective immunity remain unanswered. Onur Boyman, head of the Department of Immunology, and his research team at the ...
Feb 2, 2022
0
124
Melbourne researchers have developed a tool to monitor mutations that make it difficult to develop coronavirus (COVID-19) vaccines and drugs.
Sep 10, 2020
0
69
Around 20% of those who have recovered from COVID-19 fail to develop immune protection against SARS-CoV-2, according to a MedUni Vienna research team led by allergist and immunologist Rudolf Valenta from the Center for Pathophysiology, ...
Aug 30, 2021
0
316
